---
title: "United Therapeutics updates financial calendar ahead of quarterly results release, webcast"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293461994.md"
description: "United Therapeutics has updated its financial calendar, announcing the release of its second-quarter 2026 financial results on August 5, 2026, at approximately 6:30 a.m. ET. A public webcast for the earnings call is scheduled for the same day at 9:00 a.m. ET."
datetime: "2026-07-22T11:00:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293461994.md)
  - [en](https://longbridge.com/en/news/293461994.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293461994.md)
---

# United Therapeutics updates financial calendar ahead of quarterly results release, webcast

-   United Therapeutics schedules release of second-quarter 2026 financial results for Aug. 5, 2026, around 6:30 a.m. ET. \* Public webcast set for Aug. 5, 2026, at 9 a.m. ET via here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260722901581) on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md)

## Related News & Research

- [United Therapeutics director Victor J. Dzau files initial beneficial ownership statement](https://longbridge.com/en/news/293665860.md)
- [United Therapeutics CEO Martine Rothblatt reports sale of 9,500 common shares worth $5.04 million](https://longbridge.com/en/news/293919982.md)
- [United Therapeutics Chairperson and CEO Martine Rothblatt disposes of USD 4.93 million in common shares](https://longbridge.com/en/news/293795161.md)
- [Bowen Hanes & Co. Inc. Makes New Investment in United Therapeutics Corporation $UTHR](https://longbridge.com/en/news/293721433.md)
- [Mersen to report first-half 2026 results, host webcast](https://longbridge.com/en/news/294304901.md)